Day One Biopharmaceuticals Inc (DAWN) stock news · rev $158.2M
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
This DAWN news page leads with what Day One Biopharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for DAWN yet. We will not pad this page with generic market recap.
Latest reported DAWN revenue for 2025-12-31 was $158.2M. Net income was -$107.3M. Revenue was up 20.6% from 2024-12-31 to 2025-12-31. DAWN currently screens at market cap $656.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the DAWN stock page; for the tape open the quote page.
DAWN stock news FAQ
What are DAWN's latest revenue and net income?
Latest cached Day One Biopharmaceuticals Inc (DAWN) revenue for Dec 31, 2025 was $158.2M. Net income was -$107.3M. Statements: https://lician.com/financials/dawn
How did DAWN revenue change from the prior cached period?
Cached Day One Biopharmaceuticals Inc (DAWN) revenue was up 20.6% from $131.2M (Dec 31, 2024) to $158.2M (Dec 31, 2025). Statements: https://lician.com/financials/dawn
What is DAWN's market cap?
Day One Biopharmaceuticals Inc (DAWN) market cap is $656.8M on the latest cached fundamentals snapshot.
What kind of company is DAWN?
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Where is DAWN stock news listed?
Cached stock news for Day One Biopharmaceuticals Inc (DAWN) is listed at https://lician.com/news/dawn. Filings: https://lician.com/sec/dawn
Not investment advice.